Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

JOHNSON & JOHNSON JNJ

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).


NYSE:JNJ - Post by User

Post by robertsmith02on Aug 23, 2022 4:15am
262 Views
Post# 34913307

Ophthalmic Lasers Market to Grow at 5.07% CAGR by 2027

Ophthalmic Lasers Market to Grow at 5.07% CAGR by 2027

The latest research study, "Ophthalmic Lasers Market: Global Industry Trends, Size, Growth, Opportunity and Forecast 2022-2027" has been added by IMARC Group. The global ophthalmic lasers market reached US$ 1.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 1.6 Billion by 2027, exhibiting a growth rate (CAGR) of 5.07% during 2022-2027.

COVID-19 Impact Analysis

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

An ophthalmic laser is a type of medical device used to treat cells in the eye and treat ophthalmic conditions. The laser beam creates a concentrated area of brilliant, monochromatic light inside the eye. It also has a laser pump, cooling system, laser medium, laser cavity, and a slit lamp biomicroscope in addition to the laser beam. These lasers offer pain-free procedures and are easily available, accurate, low-cost, safe to operate, and convenient to use. Ophthalmic lasers are used for performing various procedures, such as cataract surgery, posterior capsulotomy, retinal photocoagulation, laser trabeculoplasty, and laser iridotomy.

Request for a free sample copy of this report:https://www.imarcgroup.com/ophthalmic-lasers-market/requestsample

Global Ophthalmic Lasers Industry Trends and Drivers:

The rising desire for painless, cost-effective ophthalmic therapies is driving the global market for ophthalmic lasers. Concurrently, the need for efficient laser eye operations to avoid blindness and other vision impairments has increased due to the rising prevalence of chronic and contagious eye illnesses. Additionally, the demand for ophthalmic lasers is catalyzed by the growing geriatric population, which suffers from several age-related problems, such as glaucoma, diabetic eye diseases, and cataracts.

Moreover, technological advancements in surgical procedures have enhanced the accuracy and success rates of ophthalmic laser surgeries, which is creating a positive impact on the market further. Apart from this, rising regulatory approvals for new products, extensive research and development (R&D) activities in the eye-care segment, escalating concerns for vision-health management, and the rising establishment of ophthalmic clinics and hospitals are contributing to the market growth.

Browse full report with detailed TOC and list of figures and tables: https://www.imarcgroup.com/ophthalmic-lasers-market

Market Summary:

  • On the basis of the product type, the market has been divided into diode lasers, femtosecond lasers, excimer lasers, Nd: YAG lasers, SLT lasers, and others.
  • Based on the indication, the market has been segmented into glaucoma, cataract removal, refractive error corrections, diabetic retinopathy, and others.
  • On the basis of the end user, the market has been segregated into hospitals, eye clinics and others.
  • On a regional basis, the market has been spread across North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Alcon Laboratories Inc. (Novartis AG), Johnson & Johnson Surgical Vision Inc., Bausch + Lomb, Ellex Medical Lasers Limited, IRIDEX Corporation, Lumenis, Topcon, A.R.C. Laser,

About Us

 

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact Us

30 N Gould St

Ste R

Sheridan, WY 82801

USA

Email: sales@imarcgroup.com

Website: https://www.imarcgroup.com

Follow us on twitter: @imarcglobal


<< Previous
Bullboard Posts
Next >>